Low molecular mass dermatan sulfate modulates endothelial cells proliferation and migration

Carbohydr Res. 2012 Jul 15:356:233-7. doi: 10.1016/j.carres.2012.03.036. Epub 2012 Apr 5.

Abstract

Low molecular mass dermatan sulfate, obtained by depolymerization, induced the entrance in S phase of mitosis, enhanced the activity of matrix metalloproteinase-2, and could modulate cell migration of endothelial cells, through mechanisms independent of TNF-α autocrine regulation. LMMDS located at the injured sites could influence early stages of angiogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Dermatan Sulfate / pharmacology*
  • Endothelial Cells / cytology
  • Endothelial Cells / drug effects*
  • Endothelial Cells / metabolism
  • Matrix Metalloproteinase 2 / genetics
  • Matrix Metalloproteinase 2 / metabolism*
  • Mice
  • Molecular Weight
  • Myocardium / cytology
  • S Phase / drug effects
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Tumor Necrosis Factor-alpha / metabolism
  • Up-Regulation

Substances

  • Tumor Necrosis Factor-alpha
  • Dermatan Sulfate
  • Matrix Metalloproteinase 2